Bio-Path Holdings, Inc. (BPTH) Social Stream



Bio-Path Holdings, Inc. (BPTH): $2.27

0.12 (-5.02%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add BPTH to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#194 of 348

in industry

BIO-PATH HOLDINGS INC (BPTH) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering BPTH.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-03-14 1 $13 $12 $12.5 $0.53 2258.49%
2022-05-17 2 $13 $12 $12.5 $0.53 2258.49%
2023-03-17 2 $13 $9 $11 $0.53 1975.47%
2023-05-12 1 $13 $13 $13 $0.53 2352.83%
2023-11-15 1 $12 $12 $12 $0.53 2164.15%

Price Target Last Issued May 12, 2023

The Trend in the Analyst Price Target


BPTH's average price target has moved down $0.5 over the prior 26 months.

BPTH reports an average of 1,422.38% for its upside potential over the past 35 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-17 2 13 13 13 1.560 733.33%
2023-03-17 2 13 9 11 1.560 605.13%
2023-05-12 1 13 13 13 1.480 778.38%
2023-08-10 1 12 12 12 0.427 2710.3%
2023-11-15 1 12 12 12 0.534 2147.19%

BPTH Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


Over the past 18 months, BPTH's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BPTH as an investment opportunity.

  • BIO-PATH HOLDINGS INC's number of analysts covering the stock is higher than 5.66% of all US stocks.
  • BPTH has a greater upside potential (average analyst target price relative to current price) than 593.52% of all US stocks.
  • BIO-PATH HOLDINGS INC's variance in analysts' estimates is lower than 48.14% of Pharmaceutical Products stocks.
  • In terms of how BIO-PATH HOLDINGS INC fares relative to Healthcare stocks, note that its average analyst price target is higher than 127.13% of that group.

Stocks similar to BIO-PATH HOLDINGS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ONTX, ADXS, and NWBO.

Make investment decisions regarding BPTH using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!